Challenges in Chromatography

Processing times can be reduced and yields increased by utilizing new hydrophobic interaction chromatography tools

By Dr Nandu Deorkar at Avantor

Advances in protein and peptide engineering continue, enabling the creation of new biological products with improved therapeutic and diagnostic potential. Bringing these promising biologics to market effectively depends, in part, on solving significant downstream purification process challenges – such as separation of closely related impurities – that are the result of the increased complexity of producing these biologics.

Platform-based chromatographic approaches have been successful in separating and purifying monoclonal antibody products, but the newer generations of biologics feature different hurdles for purification process developers to overcome. Product- and process-related impurities, including host cell protein, aggregates, and charge and glycosylation variants, are persistent and often difficult to separate. As a result, process developers are increasingly exploring mixed-mode and multimode chromatographic media to achieve these separations.

Continue reading article

Solutions for bioprocessing

From the small-scale bench to full commercial manufacturing, we enable our customers to reach the market with new treatments for patients, faster and safer. Learn more about our offering for biopharmaceutical manufacturing.

Avantor®, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. One of our greatest strengths comes from having a global infrastructure that is strategically located to support the needs of our customers. Our global footprint enables us to serve more than 225,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world.